Bruker (BRKR) Invested Capital (2009 - 2026)

Bruker has reported Invested Capital for 18 years, with the latest figure at $2.5 billion in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital rose 32.33% year-over-year to $2.5 billion; the trailing twelve-month figure through Mar 2026 stood at $2.5 billion (up 32.33% YoY), and the FY2025 full-year result was $2.5 billion, up 38.17% from the prior year.
• Invested Capital for Q1 2026 stood at $2.5 billion, down from $2.5 billion in the prior quarter.
• The five-year high for Invested Capital was $2.5 billion in Q4 2025, with the low at $965.0 million in Q3 2022.
• Historically, Invested Capital has averaged $1.6 billion across 5 years, with a median of $1.5 billion in 2023.
• Annual changes were most pronounced in 2022 — Invested Capital slumped 53.13% — and 2023, when it soared 39.7%.
• Bruker's Invested Capital stood at $1.1 billion in 2022, then jumped by 33.69% to $1.5 billion in 2023, then increased by 18.89% to $1.8 billion in 2024, then jumped by 38.17% to $2.5 billion in 2025, then slipped by 0.59% to $2.5 billion in 2026.
• The last three Invested Capital figures came in at $2.5 billion (Q1 2026), $2.5 billion (Q4 2025), and $2.5 billion (Q3 2025), per Business Quant data.